The global market for Companion Diagnostic Tests in Oncology was valued at US$ 4785 million in the year 2024 and is projected to reach a revised size of US$ 8953 million by 2031, growing at a CAGR of 9.5% during the forecast period.

Companion Diagnostic Tests in Oncology Market

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic Tests in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic Tests in Oncology.

The Companion Diagnostic Tests in Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Companion Diagnostic Tests in Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Companion Diagnostic Tests in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Companion Diagnostic Tests in Oncology Market Report

Report Metric	Details
Report Name	Companion Diagnostic Tests in Oncology Market
Accounted market size in year	US$ 4785 million
Forecasted market size in 2031	US$ 8953 million
CAGR	9.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Protein Detection DNA Detection
Segment by Application	Pharmaceutical & Biotechnology Companies Medical Device Companies Research Institutes Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Roche, Genomic Health, QIAGEN, Agilent, Agendia, BioMerieux, Illumina, Siemens Healthcare, Thermo Fisher
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostic Tests in Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Companion Diagnostic Tests in Oncology Market growing?

Ans: The Companion Diagnostic Tests in Oncology Market witnessing a CAGR of 9.5% during the forecast period 2025-2031.

What is the Companion Diagnostic Tests in Oncology Market size in 2031?

Ans: The Companion Diagnostic Tests in Oncology Market size in 2031 will be US$ 8953 million.

Who are the main players in the Companion Diagnostic Tests in Oncology Market report?

Ans: The main players in the Companion Diagnostic Tests in Oncology Market are Abbott, Roche, Genomic Health, QIAGEN, Agilent, Agendia, BioMerieux, Illumina, Siemens Healthcare, Thermo Fisher

What are the Application segmentation covered in the Companion Diagnostic Tests in Oncology Market report?

Ans: The Applications covered in the Companion Diagnostic Tests in Oncology Market report are Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Institutes, Others

What are the Type segmentation covered in the Companion Diagnostic Tests in Oncology Market report?

Ans: The Types covered in the Companion Diagnostic Tests in Oncology Market report are Protein Detection, DNA Detection

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Protein Detection

1.2.3 DNA Detection

1.3 Market by Application

1.3.1 Global Companion Diagnostic Tests in Oncology Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical & Biotechnology Companies

1.3.3 Medical Device Companies

1.3.4 Research Institutes

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2020-2031)

2.2 Global Companion Diagnostic Tests in Oncology Growth Trends by Region

2.2.1 Global Companion Diagnostic Tests in Oncology Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Companion Diagnostic Tests in Oncology Historic Market Size by Region (2020-2025)

2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Region (2026-2031)

2.3 Companion Diagnostic Tests in Oncology Market Dynamics

2.3.1 Companion Diagnostic Tests in Oncology Industry Trends

2.3.2 Companion Diagnostic Tests in Oncology Market Drivers

2.3.3 Companion Diagnostic Tests in Oncology Market Challenges

2.3.4 Companion Diagnostic Tests in Oncology Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue

3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2020-2025)

3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2020-2025)

3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Companion Diagnostic Tests in Oncology Revenue

3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio

3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2024

3.5 Global Key Players of Companion Diagnostic Tests in Oncology Head office and Area Served

3.6 Global Key Players of Companion Diagnostic Tests in Oncology, Product and Application

3.7 Global Key Players of Companion Diagnostic Tests in Oncology, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Tests in Oncology Breakdown Data by Type

4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2020-2025)

4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2026-2031)

5 Companion Diagnostic Tests in Oncology Breakdown Data by Application

5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2020-2025)

5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Companion Diagnostic Tests in Oncology Market Size (2020-2031)

6.2 North America Companion Diagnostic Tests in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025)

6.4 North America Companion Diagnostic Tests in Oncology Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2020-2031)

7.2 Europe Companion Diagnostic Tests in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025)

7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (2020-2031)

8.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2020-2025)

8.4 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Companion Diagnostic Tests in Oncology Market Size (2020-2031)

9.2 Latin America Companion Diagnostic Tests in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025)

9.4 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size (2020-2031)

10.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025)

10.4 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction

11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction

11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Genomic Health

11.3.1 Genomic Health Company Details

11.3.2 Genomic Health Business Overview

11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction

11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.3.5 Genomic Health Recent Development

11.4 QIAGEN

11.4.1 QIAGEN Company Details

11.4.2 QIAGEN Business Overview

11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction

11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.4.5 QIAGEN Recent Development

11.5 Agilent

11.5.1 Agilent Company Details

11.5.2 Agilent Business Overview

11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction

11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.5.5 Agilent Recent Development

11.6 Agendia

11.6.1 Agendia Company Details

11.6.2 Agendia Business Overview

11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction

11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.6.5 Agendia Recent Development

11.7 BioMerieux

11.7.1 BioMerieux Company Details

11.7.2 BioMerieux Business Overview

11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction

11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.7.5 BioMerieux Recent Development

11.8 Illumina

11.8.1 Illumina Company Details

11.8.2 Illumina Business Overview

11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction

11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.8.5 Illumina Recent Development

11.9 Siemens Healthcare

11.9.1 Siemens Healthcare Company Details

11.9.2 Siemens Healthcare Business Overview

11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction

11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.9.5 Siemens Healthcare Recent Development

11.10 Thermo Fisher

11.10.1 Thermo Fisher Company Details

11.10.2 Thermo Fisher Business Overview

11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction

11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025)

11.10.5 Thermo Fisher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Protein Detection

Table 3. Key Players of DNA Detection

Table 4. Global Companion Diagnostic Tests in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Companion Diagnostic Tests in Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Companion Diagnostic Tests in Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Companion Diagnostic Tests in Oncology Market Share by Region (2020-2025)

Table 8. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Companion Diagnostic Tests in Oncology Market Share by Region (2026-2031)

Table 10. Companion Diagnostic Tests in Oncology Market Trends

Table 11. Companion Diagnostic Tests in Oncology Market Drivers

Table 12. Companion Diagnostic Tests in Oncology Market Challenges

Table 13. Companion Diagnostic Tests in Oncology Market Restraints

Table 14. Global Companion Diagnostic Tests in Oncology Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Companion Diagnostic Tests in Oncology Market Share by Players (2020-2025)

Table 16. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2024)

Table 17. Ranking of Global Top Companion Diagnostic Tests in Oncology Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Tests in Oncology Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Companion Diagnostic Tests in Oncology, Headquarters and Area Served

Table 20. Global Key Players of Companion Diagnostic Tests in Oncology, Product and Application

Table 21. Global Key Players of Companion Diagnostic Tests in Oncology, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Companion Diagnostic Tests in Oncology Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2020-2025)

Table 25. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2026-2031)

Table 27. Global Companion Diagnostic Tests in Oncology Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2020-2025)

Table 29. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2026-2031)

Table 31. North America Companion Diagnostic Tests in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Companion Diagnostic Tests in Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Companion Diagnostic Tests in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Companion Diagnostic Tests in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2026-2031) & (US$ Million)

Table 46. Abbott Company Details

Table 47. Abbott Business Overview

Table 48. Abbott Companion Diagnostic Tests in Oncology Product

Table 49. Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 50. Abbott Recent Development

Table 51. Roche Company Details

Table 52. Roche Business Overview

Table 53. Roche Companion Diagnostic Tests in Oncology Product

Table 54. Roche Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 55. Roche Recent Development

Table 56. Genomic Health Company Details

Table 57. Genomic Health Business Overview

Table 58. Genomic Health Companion Diagnostic Tests in Oncology Product

Table 59. Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 60. Genomic Health Recent Development

Table 61. QIAGEN Company Details

Table 62. QIAGEN Business Overview

Table 63. QIAGEN Companion Diagnostic Tests in Oncology Product

Table 64. QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 65. QIAGEN Recent Development

Table 66. Agilent Company Details

Table 67. Agilent Business Overview

Table 68. Agilent Companion Diagnostic Tests in Oncology Product

Table 69. Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 70. Agilent Recent Development

Table 71. Agendia Company Details

Table 72. Agendia Business Overview

Table 73. Agendia Companion Diagnostic Tests in Oncology Product

Table 74. Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 75. Agendia Recent Development

Table 76. BioMerieux Company Details

Table 77. BioMerieux Business Overview

Table 78. BioMerieux Companion Diagnostic Tests in Oncology Product

Table 79. BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 80. BioMerieux Recent Development

Table 81. Illumina Company Details

Table 82. Illumina Business Overview

Table 83. Illumina Companion Diagnostic Tests in Oncology Product

Table 84. Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 85. Illumina Recent Development

Table 86. Siemens Healthcare Company Details

Table 87. Siemens Healthcare Business Overview

Table 88. Siemens Healthcare Companion Diagnostic Tests in Oncology Product

Table 89. Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 90. Siemens Healthcare Recent Development

Table 91. Thermo Fisher Company Details

Table 92. Thermo Fisher Business Overview

Table 93. Thermo Fisher Companion Diagnostic Tests in Oncology Product

Table 94. Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2020-2025) & (US$ Million)

Table 95. Thermo Fisher Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Companion Diagnostic Tests in Oncology Picture

Figure 2. Global Companion Diagnostic Tests in Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2024 VS 2031

Figure 4. Protein Detection Features

Figure 5. DNA Detection Features

Figure 6. Global Companion Diagnostic Tests in Oncology Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Companion Diagnostic Tests in Oncology Market Share by Application: 2024 VS 2031

Figure 8. Pharmaceutical & Biotechnology Companies Case Studies

Figure 9. Medical Device Companies Case Studies

Figure 10. Research Institutes Case Studies

Figure 11. Others Case Studies

Figure 12. Companion Diagnostic Tests in Oncology Report Years Considered

Figure 13. Global Companion Diagnostic Tests in Oncology Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Companion Diagnostic Tests in Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Companion Diagnostic Tests in Oncology Market Share by Region: 2024 VS 2031

Figure 16. Global Companion Diagnostic Tests in Oncology Market Share by Players in 2024

Figure 17. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2024

Figure 19. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Companion Diagnostic Tests in Oncology Market Share by Country (2020-2031)

Figure 21. United States Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Companion Diagnostic Tests in Oncology Market Share by Country (2020-2031)

Figure 25. Germany Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Companion Diagnostic Tests in Oncology Market Share by Region (2020-2031)

Figure 33. China Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Companion Diagnostic Tests in Oncology Market Share by Country (2020-2031)

Figure 41. Mexico Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Companion Diagnostic Tests in Oncology Market Share by Country (2020-2031)

Figure 45. Turkey Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Companion Diagnostic Tests in Oncology Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 49. Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 50. Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 51. QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 52. Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 53. Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 54. BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 55. Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 56. Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 57. Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions